Cancer, Metastatic Clinical Trials

12 recruitingLast updated: June 17, 2026

There are 12 actively recruiting cancer, metastatic clinical trials across 9 countries. Studies span Phase 1, Phase 2, Early Phase 1, Not Applicable, Phase 3. Top locations include Naples, Italy, Roma, RM, Italy, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Cancer, Metastatic Trials at a Glance

12 actively recruiting trials for cancer, metastatic are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Naples, Roma, and Boston. Lead sponsors running cancer, metastatic studies include Cedars-Sinai Medical Center, Fondazione IRCCS Policlinico San Matteo di Pavia, and Canadian Cancer Trials Group.

Browse cancer, metastatic trials by phase

Treatments under study

About Cancer, Metastatic Clinical Trials

Looking for clinical trials for Cancer, Metastatic? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer, Metastatic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer, Metastatic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases

Cancer, Metastatic
Canadian Cancer Trials Group230 enrolled9 locationsNCT06391242
Recruiting
Phase 1

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

Metastatic Solid TumorCancer, Metastatic
Valley Health System72 enrolled1 locationNCT05232409
Recruiting
Early Phase 1

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University36 enrolled1 locationNCT06937567
Recruiting

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

CancerSurvivorshipCancer, Metastatic+1 more
UNC Lineberger Comprehensive Cancer Center500 enrolled1 locationNCT05096923
Recruiting
Phase 1

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

CancerSolid Tumor, AdultCancer, Metastatic+3 more
Shenzhen Ionova Life Sciences Co., Ltd.78 enrolled3 locationsNCT04443088
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 2

Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

Colorectal, CancerRectal AdenocarcinomaColorectal Adenocarcinoma+4 more
Gruppo Oncologico del Nord-Ovest42 enrolled28 locationsNCT07407465
Recruiting
Phase 1

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Breast Cancer MetastaticHER2-Negative Breast CarcinomaPancreatic Cancer+17 more
General Oncology, Inc.24 enrolled2 locationsNCT04150042
Recruiting

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Cancer, MetastaticTraumaPathologic Fracture
Massachusetts General Hospital100 enrolled1 locationNCT04842266
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting

The Italian Registry of Malnutrition in Oncology

CancerCancer, Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia1,500 enrolled16 locationsNCT06337019
Recruiting
Phase 2

Improving Public Cancer Care by Implementing Precision Medicine in Norway

Cancer, Metastatic
Oslo University Hospital3,000 enrolled17 locationsNCT04817956